IMITREX 100 mg/1 (Sumatriptan TABLET, FILM COATED) 100 mg/1

IMITREX 100 mg tablets contain sumatriptan, a medication used for migraine relief. This film-coated tablet is designed for oral administration and is manufactured by GlaxoSmithKline LLC in the USA.

Strength

100 mg/1

Pack Size

1 CARTON in 1 CARTON (0173-0737-01) / 1 BLISTER PACK in 1 CARTON / 9 TABLET, FILM COATED in 1 BLIST

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

IMITREX 100 mg tablets are commonly used for the treatment of migraines with or without aura in adults. Sumatriptan, the active ingredient, is often sought after for its potential to alleviate migraine symptoms such as headache, nausea, and sensitivity to light and sound. People often ask, 'What is IMITREX used for?' and the primary answer is migraine relief.

Side Effects

When taken as directed, IMITREX 100 mg tablets may help reduce the severity and duration of migraine attacks. Some users report feeling relief within a few hours of taking the medication. However, individual responses can vary, and not everyone will experience the same effects.

Precautions & Warnings

IMITREX 100 mg tablets should be handled with care. It is important to follow the instructions provided by your healthcare professional. Store the medication in a cool, dry place away from direct sunlight. Always check the packaging for any signs of damage before use.

Avoid Interactions

IMITREX 100 mg tablets may interact with other medications, including certain antidepressants, ergotamines, and other migraine treatments. It is advisable to consult with a healthcare professional before combining sumatriptan with other drugs. Additionally, avoid consuming alcohol while taking this medication.

Frequently Asked Questions

IMITREX 100 mg tablets are primarily used for the treatment of migraines with or without aura in adults.

IMITREX 100 mg tablets are designed for oral administration. Follow the instructions provided by your healthcare professional.

Common side effects may include dizziness, nausea, and fatigue. Individual responses can vary.

IMITREX may interact with certain medications. Consult your healthcare professional before combining it with other drugs.

Store IMITREX 100 mg tablets in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.